Showing results (2621-2630 of 4,578) with videos related to

Sort By:
Pageof 458
European Journal of Pharmacology|June 2, 1994
Studies on the goiter inhibiting action of iodolactonesM A Pisarev, L Krawiec, G J Juvenal, et al.
Cadernos De Saude Publica|October 24, 2009
Health related quality of life among the elderly: a population-based study using SF-36 surveyMargareth Guimarães Lima, Marilisa Berti de Azevedo Barros, Chester Luiz Galvão César, et al.
Heart, Lung & Circulation|July 3, 2007
Antioxidant properties of the internal thoracic artery and the radial arteryOmar Mangoush, Thanos Athanasiou, Koki Nakamura, et al.
Journal of Neurology|May 18, 2007
Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson's diseaseNicolaas I Bohnen, Satyanarayana Gedela, Hiroto Kuwabara, et al.
Life Sciences|December 22, 1986
Photoaffinity labelling of a 33-35,000 dalton protein in cardiac, skeletal and smooth muscle membranes using a new 125I-labelled 1,4-dihydropyridine calcium channel antagonistJ G Sarmiento, P M Epstein, W A Rowe, et al.
BMJ Open|November 14, 2019
Examining satisfaction of older adult patients and their caregivers following traumatic injury: a cross-sectional study of three level I trauma centresRebecca Vogel, Constance McGraw, Alessandro Orlando, et al.
Scientific Reports|October 19, 2016
Influence of age on androgen deprivation therapy-associated Alzheimer's diseaseKevin T Nead, Greg Gaskin, Cariad Chester, et al.
The International Journal of Eating Disorders|October 19, 2016
Dopaminergic activity and altered reward modulation in anorexia nervosa-insight from multimodal imagingUrsula F Bailer, Julie C Price, Carolyn C Meltzer, et al.
The Journal of Clinical Psychiatry|May 29, 2008
An open-label, prospective study of repetitive transcranial magnetic stimulation (rTMS) in the long-term treatment of refractory depression: reproducibility and duration of the antidepressant effect in medication-free patientsAsli Demirtas-Tatlidede, Dawn Mechanic-Hamilton, Daniel Z Press, et al.
Molecular Genetics and Metabolism Reports|January 26, 2017
Pilot study of the safety and effect of adalimumab on pain, physical function, and musculoskeletal disease in mucopolysaccharidosis types I and IILynda E Polgreen, Alicia Kunin-Batson, Kyle Rudser, et al.
Pageof 458